People want radiology reports, discussions with docs Most patients want to receive imaging results directly from the doctor who sent them for scans, but many also want to see their radiology reports, a survey finds.
VBL Therapeutics' brain cancer drug succeeds in mid-stage study Israel-based VBL Therapeutics said a mid-stage study of its experimental brain cancer drug met the main goal of increasing overall survival.
Bald and strong: Nonprofit raises cancer awareness, challenges vanity Showing support for cancer comes in many forms— but would you go bald for it? That’s the challenge issued by Be Bold, Be Bald!, a campaign by non-profit Small Army for a Cause.
Quest Diagnostics, French agency seek to expand breast cancer gene database Quest Diagnostics Inc, the world's largest provider of diagnostic testing services, is working with France's national health agency to build an expanded database for BRCA1 and BRCA2 gene mutations to better determine patient hereditary risks of breast and ovarian cancer.
Some indoor tanning locations may attract 'high-risk' tanners People who go tanning at gyms or beauty shops may have riskier tanning habits than those who go to tanning salons, new research finds
Study supports watch-and-wait approach for many prostate cancers In a long-term study of older men diagnosed with low-risk prostate cancer and followed with so-called active surveillance, less than a third of cases eventually needed treatment, according to a new study.
Genetic counseling is rare among BRCA-tested women Although counseling is widely recommended before gene testing, most U.S. women who were sent by doctors to be tested for BRCA1 and BRCA2, two genes that increase the risk of breast and ovarian cancer, never met with a counselor beforehand.
US strengthens rules to protect farm workers from pesticides An estimated 2 million U.S. farm workers, children and others who work or live near farm fields will have more protection from hazardous pesticides under changes unveiled Monday by federal officials.
Hormone replacement therapy linked to increased risk of ovarian cancer, study finds An analysis of over 50 studies suggests an association between short-term use of hormone replacement therapy (HRT) during menopause and a 40 percent increased risk of developing ovarian cancer.
New test can determine effectiveness of cancer treatment within 16 hours Researchers at Dana Farber Cancer Institute in Boston have developed a new technique that can predict which specific drug will be most effective in treating various types of cancer tumors.
